FDA Clearance Tracker · P040044-S034
MYNX VASCULAR CLOSURE DEVICE WITH GRIP TECHNOLOGY
Last checked: Nov 20, 2026Latest source record: Oct 4, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Oct 4, 2011
Approved
Time to decision
369 days
Received Sep 30, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P040044-S034
- Device name
- MYNX VASCULAR CLOSURE DEVICE WITH GRIP TECHNOLOGY
- Applicant
- Cordis US Corporation
- Applicant location
- Miami Lakes, FL
- Received
- Sep 30, 2010
- Decided
- Oct 4, 2011
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P040044
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MODIFIED VERSION OF THE MYNX VASCULAR CLOSURE DEVICE CALLED THE MYNX VASCULAR CLOSURE DEVICE WITH GRIP TECHNOLOGY.
Source documents
Other decisions for Cordis US Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.